Wolverine Trading’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 2010 |
|
|
2025
Q1 | – | Sell |
-31,015
| Closed | -$354K | – | 2064 |
|
|
2024
Q4 | $354K | Buy |
31,015
+20,314
| +190% | +$232K | ﹤0.01% | 986 |
|
|
2024
Q3 | $225K | Sell |
10,701
-768
| -7% | -$16.1K | ﹤0.01% | 1034 |
|
|
2024
Q2 | $257K | Buy |
11,469
+571
| +5% | +$12.8K | ﹤0.01% | 923 |
|
|
2024
Q1 | $300K | Sell |
10,898
-913
| -8% | -$25.1K | ﹤0.01% | 802 |
|
|
2023
Q4 | $360K | Buy |
11,811
+1,028
| +10% | +$31.3K | ﹤0.01% | 821 |
|
|
2023
Q3 | $341K | Buy |
10,783
+4,315
| +67% | +$136K | ﹤0.01% | 720 |
|
|
2023
Q2 | $265K | Buy |
+6,468
| New | +$265K | ﹤0.01% | 747 |
|
|
2023
Q1 | – | Sell |
-7,964
| Closed | -$278K | – | 1759 |
|
|
2022
Q4 | $278K | Buy |
7,964
+3,719
| +88% | +$130K | ﹤0.01% | 629 |
|
|
2022
Q3 | $235K | Sell |
4,245
-231
| -5% | -$12.8K | ﹤0.01% | 835 |
|
|
2022
Q2 | $235K | Sell |
4,476
-719
| -14% | -$37.7K | ﹤0.01% | 817 |
|
|
2022
Q1 | $375K | Sell |
5,195
-362
| -7% | -$26.1K | ﹤0.01% | 890 |
|
|
2021
Q4 | $674K | Sell |
5,557
-992
| -15% | -$120K | ﹤0.01% | 738 |
|
|
2021
Q3 | $901K | Buy |
6,549
+4,277
| +188% | +$588K | ﹤0.01% | 724 |
|
|
2021
Q2 | $344K | Sell |
2,272
-6,100
| -73% | -$924K | ﹤0.01% | 1165 |
|
|
2021
Q1 | $605K | Buy |
+8,372
| New | +$605K | ﹤0.01% | 862 |
|